PatternsRadar
Sign in

GPTHEALTHGPT Healthcare Limited

NSE
Full chart
148.01INR-1.55 (-1.04%)Close · 6 Oct 2026
3 Aug 2026Last results
HealthcareSector
Healthcare ServicesIndustry
₹1,214 CrMarket cap
25.7P/E (TTM)
67.6%Delivery

Filings & corporate actions

11 results filed
CSV
Next results · Q2 FY27
Expected 2 Nov 2026 – 22 Nov 2026
Estimate: filed 33–53 days after quarter end, last 8 times
Dividend
₹1.50 per share · last 30 Jul 2026
2026
  • 3 AugresultsResults · Q1 FY27 · standalone-1.1%NSE
  • 30 JuldividendDividend · ₹1.50 per share-0.7%
  • 21 JulshareholdingShareholding · 30 Jun 2026+1.3%NSE
  • 18 MayresultsResults · Q4 FY26 · standalone+2.9%NSE
  • 21 AprshareholdingShareholding · 31 Mar 2026-1.0%NSE
  • 2 FebresultsResults · Q3 FY26 · standalone+0.8%NSE
  • 19 JanshareholdingShareholding · 31 Dec 2025+0.5%NSE

Reaction to results · all yearsrose on day 0 in 3 of 11 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY273 Aug 2026-1.1%-2.1%-7.5%3.3×
Q4 FY2618 May 2026+2.9%+0.3%+4.4%1.9×
Q3 FY262 Feb 2026+0.8%+1.5%-5.7%4.1×
Q2 FY268 Nov 2025-3.4%-0.4%-5.4%2.3×
Q1 FY266 Aug 2025-9.0%-9.8%-13.0%3.6×
Q4 FY2523 May 2025-1.7%-2.7%-7.0%3.5×
Q3 FY2511 Feb 2025-2.4%-8.8%-10.7%2.7×
Q2 FY2514 Nov 2024-1.6%+4.2%+11.9%0.7×
Q1 FY2513 Aug 2024-4.2%+6.1%+6.6%0.8×
Q4 FY2421 May 2024-3.1%-11.4%-8.7%0.8×
Q3 FY2419 Mar 2024+4.5%+5.1%+0.8%—
Average-1.7%-1.6%-3.1%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+17.8%
Profit YoY+65.7%
Interest cost YoY+106.6%
Revenue QoQ-0.1%
Profit QoQ-12.6%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

CSV
Open148.42
Day range147.10 – 151.18
52-week range115.00 – 175.00
From 52w high-15.4%
RSI (14)32.3
ATR (14)5.46
Volume50.0K
Avg volume (20D)1.19L
Rel volume0.42×
Volatility (1Y)26.0%
Turnover₹74.0L
SMA 50 / 200158.07 / 142.62

Delivery percentage

Latest · 6 Oct 202667.6%
20-day avg54.2%
1-year avg57.3%
Percentile (own history)93rd
Range15.0–93.7%
Sessions644

Over the last 20 sessions GPTHEALTH settled 54.2% of its traded quantity, which is above average for an NSE equity. Its one-year average is 57.3%, so recent sessions are running 3.1 points lower than usual. The latest session ranks higher than 93% of the 644 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Performance returns

CSV
1D1W1M3M6M1Y
Price-1.04%-5.18%-3.69%-5.26%+20.02%+0.01%

Valuation

CSV
Market cap₹1,214 Cr
P/E (TTM)25.7
EPS (TTM)5.76
Shares outstanding8.21Cr
Listed29 Feb 2024

Ownership

CSV
Promoter65.57%
Promoter Δ QoQ0.00 pp
Public34.43%
FII3.03%
DII6.94%
Pledged0.00%

Quarterly results · standalone

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)118.9120.2126.4126.2
YoY chg+12.5%+17.6%+24.6%+17.8%
Net profit (₹ Cr)10.69.414.612.7
YoY chg-28.5%-23.5%+13.0%+65.7%
Net margin8.9%7.8%11.5%10.1%
EPS1.291.141.781.55

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 65.57% · public 34.43%
27 Feb 2024: promoter 65.57%31 Mar 2024: promoter 65.57%30 Jun 2024: promoter 65.57%30 Sept 2024: promoter 65.57%31 Dec 2024: promoter 65.57%31 Mar 2025: promoter 65.57%30 Jun 2025: promoter 65.57%30 Sept 2025: promoter 65.57%31 Dec 2025: promoter 65.57%31 Mar 2026: promoter 65.57%30 Jun 2026: promoter 65.57%
2024-022026-06
  • Promoter
  • Public and others
Promoter
65.57%
Public
34.43%
Promoter change
0.00 pp
Filed
21 Jul 2026
FII
3.03%
DII
6.94%
Promoter pledged
0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
Standalone
₹ crore, as filed
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations96.699.497.8105.7102.2101.4107.1118.9120.2126.4126.2
Other income1.21.62.22.81.91.61.61.31.41.62.0
Total income97.8101.0100.1108.5104.1103.0108.7120.2121.6128.0128.2
Total expenses81.882.685.487.886.586.697.6105.2108.8112.1111.1
└ Finance costs1.71.60.90.70.91.01.62.22.32.22.2
└ Depreciation4.54.84.74.84.74.96.26.87.16.96.9
Profit before tax16.018.414.720.717.616.411.115.112.815.917.2
Tax expense4.55.64.75.95.43.53.44.53.41.34.4
Net profit11.512.810.014.812.212.97.710.69.414.612.7
EPS1.441.591.211.811.491.570.941.291.141.781.55
Net margin11.87%12.89%10.19%14.03%11.98%12.71%7.17%8.92%7.80%11.53%10.09%
PBT margin16.55%18.52%15.00%19.58%17.24%16.14%10.38%12.67%10.62%12.55%13.60%
Tax rate28.26%30.40%32.07%28.36%30.50%21.25%30.88%29.63%26.57%8.19%25.83%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 3 Aug 2026.

GPTHEALTH at a glance

  • GPTHEALTH closed at ₹148.01 on 6 Oct 2026, -1.04% on the day, +0.0% over one year, 15.4% below its 52-week high of ₹175.
  • Delivery was 67.6% of traded quantity on 6 Oct 2026, the 93rd percentile of its own 644 sessions with a reading (20-session average 54.2%, 1-year average 57.3%).
  • Market capitalisation is ₹1,214 crore at a trailing P/E of 25.7 (trailing EPS ₹5.76).
  • Q1 FY27 results (standalone, filed 3 Aug 2026): revenue ₹126 crore (+17.8% year on year), net profit ₹13 crore (+65.7%); the price moved -1.1% on the first session after.
  • Promoters held 65.57% at 30 Jun 2026, unchanged on the previous filing.
  • Q2 FY27 results are expected between 2 Nov 2026 and 22 Nov 2026, going by past filing dates — an estimate, not an announcement.